Centrul Medical Endocrinologie si Diabet Dr. Paveliu

Bucharest, Bucharest 50538

0 studies enrolling now · 2 studies all time

What they study most

Lipoprotein Disorder, Type 2 Diabetes

Studies at this site

• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor — Completed
• A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] — Completed